港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

894.734

+12.0711.37%

涨家数：15

跌家数：3

平家数：- -

市盈率：- -

高：904.973

开：882.576

低：882.576

收：882.663

数据加载中...

富国基金朱少醒：一季度加仓比亚迪和宁波银行

双面马应龙：一边业绩回归增长，一边深陷“回流药风波”

港股异动 | 石药集团(01093)尾盘涨超10%暂领涨蓝筹 SYS 6041获FDA批准在美开展临床研究

智通财经网

君实生物等在上海投资成立生物科技公司

中国生物制药盘中异动下午盘大幅拉升5.18%

医药股领涨，信达生物涨超10%，港股科技50ETF（159750）涨1.74%

A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史

复星医药，增持复宏汉霖至63.43%

济南比亚迪半导体申请图像生成专利，保障目标图像与用户视觉习惯匹配

去年北京追回医保基金4.64亿元

刘强东火锅谈话全文：“老兄弟”退休金不低于5000

港股医药逆势走强港股医药ETF涨超3% 冲击四连涨

东方财富证券

港股概念追踪|生物医药去库存周期尾声原料药+创新药受益国产替代（附概念股）

3月插混战报：吉利/奇瑞猛追比亚迪，长安/问界挑战理想

Ofweek光电信息网

复宏汉霖盘中涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权

港股异动 | 复宏汉霖(02696)再涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权

【白云山(00874.HK)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》】白云山(00874.HK)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。

诺和诺德与京东健康开启战略合作，将共同打造肥胖症科普专区

白云山(00874)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》

智通财经网

【港股医药股走强歌礼制药涨近18%】截至发稿，歌礼制药-B(01672.HK)涨17.81%、荣昌生物(09995.HK)涨10.06%、映恩生物-B(09606.HK)涨9%、来凯生物-B(02105.HK)涨8.25%。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1515/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":894.73364,"timestamp":1745395729742,"preClose":882.6631,"halted":0,"volume":484058068,"delay":0,"changeRate":0.013675,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":12.070557,"latestTime":"04-23 16:00:00","open":882.57605,"high":904.97345,"low":882.57605,"amount":4091008186.2,"amplitude":0.025375,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745458200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745371800000,1745380800000],[1745384400000,1745395200000]],"pbRate":1.600386,"peRate":21.350646,"turnoverRate":0.006361,"increases":15,"decrements":3,"flats":0,"marketCap":617536649344,"floatMarketCap":507117410432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":904.97345,"amplitude":0.025375,"preClose":882.6631,"low":882.57605,"pbRate":"1.600386","latestPrice":894.73364,"volume":484058068,"delay":0,"open":882.57605,"prevYearClose":787.97723,"prevWeekClose":849.427,"prevMonthClose":870.015,"prevQuarterClose":870.015,"fiveDayClose":871.923,"twentyDayClose":905.664,"sixtyDayClose":775.333,"secType":"PLATE","market":"HK","turnoverRate":0.006361,"peRate":21.350646,"marketCap":617536649344,"floatMarketCap":507117410432,"timestamp":1745395729742,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":15,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529345329","title":"富国基金朱少醒：一季度加仓比亚迪和宁波银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2529345329","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529345329?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 15:36","pubTimestamp":1745307390,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BD6J9T35.USD","03189","161005","LU0880133367.SGD","002142","BK1515","600519","LU0359201885.HKD","LU2476274308.USD","LU1831875114.USD","LU2177674079.SGD","LU0509642566.USD","LU0228659784.USD","EVS.SI","LU1242518857.USD","HYDD.SI","BK1539","LU0865486749.SGD","LU2495084118.USD","LU0405327494.USD","01211","LU2097828714.EUR","LU2580892862.HKD","LU0828238088.HKD","LU2399975544.HKD","002594","00285","BK0014","BYDDY","LU1051768304.USD","300910","SG9999006597.SGD","LU1997245177.USD","LU2008162690.USD","BK0188","LU0531970944.HKD","LU2153592121.USD","LU0229945570.USD","LU1934453819.USD","LU1961090484.USD","LU1515016050.SGD","81211","LU0873338254.USD","LU1226288253.USD","LU0417516902.SGD","BK1589","83189","LU0577902298.EUR","LU0054450605.USD"],"gpt_icon":0},{"id":"2529753343","title":"双面马应龙：一边业绩回归增长，一边深陷“回流药风波”","url":"https://stock-news.laohu8.com/highlight/detail?id=2529753343","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529753343?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 15:25","pubTimestamp":1745306749,"startTime":"0","endTime":"0","summary":"2024年，有着“痔疮药第一股”之称的马应龙终于重回增长轨道。4月2日晚间，马应龙披露2024年业绩财报。只不过，当下的马应龙或许难以安心享受这份成绩单带来的喜悦，因为企业刚被卷入“回流药风波”。一般来说，“回流药”往往与欺诈骗保有关，而马应龙旗下药店也正在面临调查。在走过400余年历史之后，卷入“回流药风波”的马应龙如今又要开始苦恼，如何重建市场的信任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/255688","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1515","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"2529439673","title":"港股异动 | 石药集团(01093)尾盘涨超10%暂领涨蓝筹 SYS 6041获FDA批准在美开展临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2529439673","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529439673?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 15:08","pubTimestamp":1745305680,"startTime":"0","endTime":"0","summary":"截至发稿，涨10.07%，报6.12港元，成交额10.82亿港元。消息面上，石药集团此前发布公告，集团开发的SYS 6041的试验性新药申请已获得美国FDA批准，可以在美国开展临床研究。该产品已于2025年1月获得中华人民共和国国家药品监督管理局批准在中国开展临床试验。此外，石药集团公告，集团开发的磷酸奥司他韦干混悬剂已获得中华人民共和国国家药品监督管理局颁发的药品注册批件，并视同通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzraw0888247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1807302812.USD","BK1515","LU0501845795.SGD","LU1008478684.HKD","LU1226288170.HKD","LU0140636845.USD","LU1226287529.USD","LU0326950275.SGD","LU1226287792.SGD","IE00B543WZ88.USD","BK1191","IE00BZ08YR35.GBP","SG9999004220.SGD","LU1960683339.HKD","LU0067412154.USD","BK1521","IE00BZ08YT58.USD","IE0008369823.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0880133367.SGD","01093","LU1226287875.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU1226288253.USD","LU1993786604.SGD","LU1152091168.USD","LU1951186391.HKD","IE0008368742.USD","LU0072913022.USD"],"gpt_icon":0},{"id":"2529348374","title":"君实生物等在上海投资成立生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2529348374","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529348374?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 15:06","pubTimestamp":1745305565,"startTime":"0","endTime":"0","summary":"人民财讯4月22日电，企查查APP显示，近日，乾元利康（上海）生物科技有限公司成立，法定代表人为杨艳梅，注册资本为100万元，经营范围包含：技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；医学研究和试验发展。企查查股权穿透显示，该公司由徐东生、君实生物旗下上海君拓生物医药科技有限公司等共同持股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384295184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1583","BK1161","01877"],"gpt_icon":0},{"id":"2529310201","title":"中国生物制药盘中异动 下午盘大幅拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529310201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529310201?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 15:02","pubTimestamp":1745305370,"startTime":"0","endTime":"0","summary":"2025年04月22日下午盘15时02分，中国生物制药股票出现异动，股价大幅拉升5.18%。中国生物制药股票所在的药品行业中，整体涨幅为1.14%。中国生物制药的TRD205率先进入临床2期研究，成为全球首个针对慢性术后神经痛并进入2期临床阶段的创新药。中国生物制药将镇痛列为四大核心治疗领域之一，2024年该领域收入达44.58亿元，占集团收入15.4%，较去年同期收入同比增加18.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042215025494ddbd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042215025494ddbd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","BK1191","BK1515","BK1521","BK1589"],"gpt_icon":0},{"id":"2529191223","title":"医药股领涨，信达生物涨超10%，港股科技50ETF（159750）涨1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529191223","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529191223?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 13:49","pubTimestamp":1745300963,"startTime":"0","endTime":"0","summary":"港股午后转涨，恒生指数涨0.6%，早盘一度跌近1%，医药股领涨，信达生物涨超10%，百济神州、康方生物、再鼎医药涨幅居前；互联网、芯片、汽车股纷纷跟涨，小米集团涨近6%，华虹半导体、零跑汽车涨超4%。港股科技50ETF涨1.74%，盘中成交超1亿元。截至发稿，南向资金净流入超78亿港元。港股科技50ETF已纳入融资融券标的，意味着ETF在在资产规模、持有人户数、流动性方面均满足了较高的市场要求，本身具备较高质地。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.jrj.com.cn/2025/04/22134949743697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1515","BK1161","BK1574","159750","LU2488822045.USD","LU1969619763.USD","BK1589","513980","LU2328871848.SGD","01801","159938","BK1583","09939"],"gpt_icon":0},{"id":"2529701316","title":"A股午后医药板块持续走高，创新药方向继续领涨，众生药业、华森制药、富士莱涨停，百利天恒、诺诚健华、新诺威、百济神州创历史","url":"https://stock-news.laohu8.com/highlight/detail?id=2529701316","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529701316?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 13:47","pubTimestamp":1745300842,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688068","BK0077","LU2328871848.SGD","002317","BK1191","BK0188","ONC","BK0187","688505","BK4139","06160","LU1969619763.USD","688235","301258","LU0588546209.SGD","09939","BK0183","09969","BK1583","300765","688506","BK1515","002294","159992","01349","BK1500","06978","LU0307460666.USD","399300","002907","BK0226","159938","BK1588","BK1161","688428","BK0028","159982","688091","BK1574","BK0239","BK0196"],"gpt_icon":0},{"id":"2529124313","title":"复星医药，增持复宏汉霖至63.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529124313","media":"市场资讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529124313?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 13:03","pubTimestamp":1745298180,"startTime":"0","endTime":"0","summary":"　　复星医药发公告指，上周四斥资3.68亿港元增持复宏汉霖约1494.07万股非上市股份，平均每股作价24.6港元，卖方为生物科技投资公司HenLink。　　复星医药又在4月15日与舟山果运签订股份转让协议，向对方收购138.12万股复宏汉霖非上市股份，每股代价为24.6港元，涉3397.75万港元。　　上述数项交易完成后，复星医药持有复宏汉霖股权比例会由59.56%增加至63.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-22/doc-inetzkuw4200955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK1161","BK0096","BK1593","BK0183","02196","BK0196","BK0175","BK0028","BK0012","BK0239","BK1515","600196","02696","BK0060","BK0187","BK1191"],"gpt_icon":0},{"id":"2529390545","title":"济南比亚迪半导体申请图像生成专利，保障目标图像与用户视觉习惯匹配","url":"https://stock-news.laohu8.com/highlight/detail?id=2529390545","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529390545?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 12:01","pubTimestamp":1745294502,"startTime":"0","endTime":"0","summary":"金融界2025年4月22日消息，国家知识产权局信息显示，济南比亚迪半导体技术有限公司申请一项名为“图像生成方法、控制装置、电子装置、车辆及存储介质”的专利，公开号CN119854643A，申请日期为2024年8月。通过天眼查大数据分析，济南比亚迪半导体技术有限公司共对外投资了2家企业，参与招投标项目2次，专利信息45条，此外企业还拥有行政许可1个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212130994dd9e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042212130994dd9e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1610","002594","LU0315178854.USD","BYDDY","LU0516422952.EUR","LU2097828714.EUR","LU0449515922.USD","00285","LU0516422366.SGD","LU0348825331.USD","LU0274383008.USD","LU1023057109.AUD","LU0348735423.USD","LU0593848301.USD","LU2097828805.USD","BK1119","LU1720050803.USD","BK1149","SG9999015986.USD","LU0463099449.HKD","LU1861219969.SGD","LU0289961442.SGD","LU0865486749.SGD","LU0979878070.USD","01211","LU0054450605.USD","LU0348805143.USD","LU1794554557.SGD","81211","LU0511384066.AUD","BK1504","LU0214875030.USD","LU0561508036.HKD","HYDD.SI","LU2249611893.SGD","LU0327786744.USD","LU2360107325.USD","LU1880383366.USD","LU2399975544.HKD","LU2097828474.EUR","LU1719994722.HKD","LU0143863198.USD","LU0269904917.USD","SG9999015945.SGD","LU2476274308.USD","LU0143863784.USD","LU0229945570.USD","LU1861214812.USD","BK1515","LU0516422440.USD"],"gpt_icon":1},{"id":"2529392335","title":"去年北京追回医保基金4.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529392335","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529392335?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:47","pubTimestamp":1745293635,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1515","BK1161","159938","09939","BK1574"],"gpt_icon":0},{"id":"2529391065","title":"刘强东火锅谈话全文：“老兄弟”退休金不低于5000","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391065","media":"蓝鲸新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391065?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:15","pubTimestamp":1745291726,"startTime":"0","endTime":"0","summary":"4月21日，京东创始人刘强东在亲自参与外卖配送之后，请外卖骑手们吃海底捞火锅。吃饭期间刘强东发表讲话，谈及送外卖的感受、为骑手缴纳五险一金等内容。刘强东称：“京东这种工作稳定，五险一金全齐了。我们老兄弟干了18年，他还可以照样干五年，还没到退休年龄。20多年之后，他离开京东的时候，光公积金一项就要给二三十万现金一次性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384150057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0029875118.USD","LU2242644610.SGD","LU0140636845.USD","LU0259732245.USD","LU0359202008.SGD","LU0163747925.USD","LU0417516738.SGD","LU1794554557.SGD","IE0008368742.USD","LU0315179316.USD","LU1770034418.SGD","LU0543330483.HKD","BK1583","LU0588545904.SGD","LU0048580855.USD","09618","LU1044874839.SGD","LU0307460666.USD","LU0865486749.SGD","LU0384037296.USD","SG9999001226.SGD","LU0326950275.SGD","LU0345776255.USD","06618","LU0128522157.USD","LU0588546209.SGD","BK4579","BK1515","LU1813983027.USD","LU0051755006.USD","LU1808992512.USD","LU0499858602.USD","89618","BK1591","BK1610","LU0791591158.USD","86618","BK4503","LU0531971595.HKD","LU0417516902.SGD","LU1688375341.USD","JD","LU0228367735.SGD","LU0828237510.HKD","BK4614","LU0431992006.USD","BK4505","BK1247","BK4509","LU1282649810.SGD"],"gpt_icon":1},{"id":"2529391901","title":"港股医药逆势走强 港股医药ETF涨超3% 冲击四连涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391901","media":"东方财富证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529391901?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 11:10","pubTimestamp":1745291400,"startTime":"0","endTime":"0","summary":"4月22日，港股市场集体震荡环境下，港股医药带头领涨，港股医药ETF上涨3.10%，冲击4连涨。成分股石药集团、百济神州、信达生物、再鼎医药、康方生物上涨超 5%。港股医药ETF紧密跟踪中证港股通医药卫生综合指数，中证港股通医药卫生综合指数从港股通范围内选取50只流动性较好、市值较大的医疗卫生行业上市公司证券作为指数样本，以反映港股通范围内医药卫生上市公司证券的整体表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111145a6c32f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111145a6c32f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1960683339.HKD","LU0501845795.SGD","06160","LU1807302812.USD","LU1152091168.USD","BK1515","IE0008368742.USD","LU0067412154.USD","01093","IE00BZ08YR35.GBP","BK1521","09688","IE0008369823.USD","LU1226288170.HKD","IE00B031HY20.USD","IE00B543WZ88.USD","LU0880133367.SGD","LU1226287792.SGD","LU1152091754.HKD","LU1226287529.USD","BK1191","LU0072913022.USD","LU1226288253.USD","LU0140636845.USD","LU1226287875.USD","01801","LU1993786604.SGD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU1951186391.HKD","09926","LU0326950275.SGD","IE00B5MMRT66.SGD","HSTECH","LU1008478684.HKD","SG9999004220.SGD"],"gpt_icon":1},{"id":"2529204399","title":"港股概念追踪|生物医药去库存周期尾声        原料药+创新药受益国产替代（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2529204399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529204399?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:50","pubTimestamp":1745290214,"startTime":"0","endTime":"0","summary":"探索建立生物医药企业进口研发用物品“白名单”制度，允许免予办理进口药品通关单。中国由于工程师红利、环保及成本优势过往承接全球原料药生产重心转移，为全球主工厂之一。期内总收入为21亿元人民币，其中产品销售收入20亿元人民币，同比增长25%。机构预期康方生物今年的产品销售将同比增长60%至33亿元人民币，受惠今年初AK104和AK112被纳入中国国家医保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1226288253.USD","LU0140636845.USD","IE0008369823.USD","LU0501845795.SGD","SG9999004220.SGD","LU1807302812.USD","IE0008368742.USD","159992","IE00B543WZ88.USD","LU1008478684.HKD","BK1583","LU1993786604.SGD","BK1191","LU0326950275.SGD","LU1969619763.USD","LU1152091168.USD","BK1574","IE00BZ08YT58.USD","09995","BK1515","HSTECH","LU0067412154.USD","01093","LU1960683339.HKD","IE00B031HY20.USD","LU1226287875.USD","LU1226288170.HKD","YANG","161726","LU2328871848.SGD","IE00BZ08YR35.GBP","LU1152091754.HKD","BK1161","LU1951186391.HKD","06978","BK1521","BK4614","IE00BZ08YS42.EUR","LU0072913022.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1226287529.USD","LU0880133367.SGD","399441"],"gpt_icon":1},{"id":"2529585791","title":"3月插混战报：吉利/奇瑞猛追比亚迪，长安/问界挑战理想","url":"https://stock-news.laohu8.com/highlight/detail?id=2529585791","media":"Ofweek光电信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529585791?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:45","pubTimestamp":1745289900,"startTime":"0","endTime":"0","summary":"吉利银河星舰7、银河L6分别以11890辆、8027辆的销量，成为仅次于比亚迪的插混车型。理想：遭遇长安、问界增程车挑战作为增程车市场领导者，理想汽车凭借L6、L7夺得中国增程车型销量冠、亚军，但也遭遇长安、赛力斯、奇瑞等集团的挑战。理想L6销量17,197辆，而理想L7销量已降至8707辆，同比下降19.1%。目前尚无插混/增程车型上市的企业如小鹏汽车、广汽埃安等，也计划推出插混/增程车型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042210561494dd8a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042210561494dd8a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588545490.SGD","LU0175139822.USD","BK1522","LU0634319403.HKD","LU0708995583.HKD","LU0449509016.USD","BK1539","01211","81211","BYDDY","LU1023057109.AUD","LU0516423091.SGD","LU0819123356.HKD","LU0543330566.HKD","LU0417516738.SGD","BK1515","LU0828238088.HKD","LU1861219969.SGD","LU1868837722.USD","LU0327786744.USD","SG9999002463.SGD","LU1770034418.SGD","002594","GELYY","HYDD.SI","BK1504","LU0269904917.USD","LU0315179316.USD","LU2097828714.EUR","LU1251922891.USD","LU0293314216.USD","LU0143863784.USD","LU2360107325.USD","LU0307460666.USD","LU0229945570.USD","SG9999015952.SGD","EVS.SI","LU0274383008.USD","LU0979878070.USD","SG9999001226.SGD","80175","LU0289960550.SGD","LU0516422366.SGD","SG9999014674.SGD","BK1119","LU1242518857.USD","LU1880383440.USD","00175","LU0214875030.USD"],"gpt_icon":1},{"id":"2529395970","title":"复宏汉霖盘中涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529395970","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529395970?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:42","pubTimestamp":1745289720,"startTime":"0","endTime":"0","summary":"　　复宏汉霖盘中涨超9%，截至发稿，股价上涨8.40%，现报36.80港元，成交额3593.75万港元。　　消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-22/doc-inetzepa1054800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0196","BK0239","02696","02196","600196","BK0183","BK1161","BK1191","BK0187","BK0012","BK1515","BK0175","BK1593","BK0060","BK0096","BK0188","BK0028"],"gpt_icon":0},{"id":"2529393265","title":"港股异动 | 复宏汉霖(02696)再涨超9% 复星医药拟5.17亿港元增持复宏汉霖3.87%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529393265","media":"智通财经","labels":["shareholding","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529393265?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:32","pubTimestamp":1745289125,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖再涨超9%，截至发稿，涨8.54%，报36.85港元，成交额3528.23万港元。消息面上，复星医药公布，今年4月11日至17日期间，控股子公司复星医药产业与上海善梧、无锡通善、舟山果运及Henlink分别签订转让协议，控股子公司复星医药产业拟以24.60港元/股的价格受让上海善梧、无锡通善、舟山果运及Henlink合计持有的2103万股复宏汉霖非上市股份，转让价款共计5.17亿港元。在此次增持之后，复星医药持有复宏汉霖的股权比例将增至63.43%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK1515","600196","02196","BK0060","BK0096","BK1161","BK1593","BK0012","02696","BK0175","BK0183","BK0028","BK0187","BK0188","BK1191","BK0239"],"gpt_icon":0},{"id":"2529600513","title":"【白云山(00874.HK)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》】白云山(00874.HK)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529600513","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529600513?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:08","pubTimestamp":1745287717,"startTime":"0","endTime":"0","summary":"白云山(00874.HK)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22100849738128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","BK0239","BK0012","BK0028","BK0183","600332","BK0196","BK1521","00874","BK1191","BK0096","BK1606","BK0097","BK0070","01477","BK0175","BK1574","BK1197","BK1515"],"gpt_icon":0},{"id":"2529539359","title":"诺和诺德与京东健康开启战略合作，将共同打造肥胖症科普专区","url":"https://stock-news.laohu8.com/highlight/detail?id=2529539359","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529539359?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:05","pubTimestamp":1745287505,"startTime":"0","endTime":"0","summary":"新京报讯（记者王卡拉）4月21日，京东健康与诺和诺德在北京签署战略合作协议，将携手打造肥胖症公众科普专区，助力糖尿病一站式诊疗，全面赋能慢病管理数字化转型升级。为了应对严重慢性疾病的挑战，我国将“糖尿病防治行动”列为《健康中国行动（2019-2030年）》15个专项行动之一，并持续推进《“体重管理年”活动实施方案》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504223384063334.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504223384063334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK4585","BK4007","BK1571","LU0456827905.SGD","BK1247","06618","LU1093756168.USD","LU0051755006.USD","BK1583","BK1589","LU0154236417.USD","IE00BKVL7J92.USD","BK1142","NVO","86618","BK4588","IE00BZ1G4Q59.USD","BK4599","LU1093756325.SGD","BK1591","BK4532","BK1615"],"gpt_icon":1},{"id":"2529360783","title":"白云山(00874)：明兴药业收到广东省药品监督管理局核准签发的《药品生产许可证》","url":"https://stock-news.laohu8.com/highlight/detail?id=2529360783","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529360783?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 10:05","pubTimestamp":1745287500,"startTime":"0","endTime":"0","summary":"白云山(00874)发布公告，近日，该公司子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》，同意明兴药业核减生产范围、生产车间和生产线。明兴药业白云厂区已实现规模化运作。本次核减生产范围、生产车间和生产线，有利于进一步整合生产资源、优化产能布局，继续保持稳定的生产能力，满足市场需求。本次获得《药品生产许可证》，对本公司当期业绩无重大影响。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-22/doc-inetyyey7952741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","BK0196","BK0097","BK0096","00874","BK0028","BK0183","BK1197","BK0012","BK1515","BK0239","BK1521","BK1606","BK1191","BK0070","600332","BK0188"],"gpt_icon":0},{"id":"2529367183","title":"【港股医药股走强 歌礼制药涨近18%】截至发稿，歌礼制药-B(01672.HK)涨17.81%、荣昌生物(09995.HK)涨10.06%、映恩生物-B(09606.HK)涨9%、来凯生物-B(02105.HK)涨8.25%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529367183","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529367183?lang=zh_cn&edition=fundamental","pubTime":"2025-04-22 09:55","pubTimestamp":1745286903,"startTime":"0","endTime":"0","summary":"截至发稿，歌礼制药-B(01672.HK)涨17.81%、荣昌生物(09995.HK)涨10.06%、映恩生物-B(09606.HK)涨9%、来凯生物-B(02105.HK)涨8.25%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/22095549737746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1191","BK1583","BK1515","LU2148510915.USD","01672","LU1064130708.USD","BK0239","LU1064131003.USD","LU1969619763.USD","09995","LU2328871848.SGD","01477","159718","688331","BK1574","02105"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":413,"code":"91000000","status":"200"}]}}